Our people–a story of
competence and collaboration


Cultivating a diverse set of expertise and knowledge.

We employ an exemplary set of professionals with diverse skill sets, all working toward a common goal—invested in the health and care of the patient, knowing financial returns follow well-being. Our people have come together from all over the world and represent a culture of competence and collaboration that is shaping Nan Fung Life Sciences for generations to come.


We’re solving critical challenges. Be part of the answer.
Meet our exemplary team


As Sanofi prunes pipeline, ex-Alexion crew at Rallybio picks up anemia drug

Sanofi has out-licensed its KY1066 antibody to New Haven, CT-based Rallybio who has redubbed it RLYB331. The deal saw Rallybio…

Abbvie and Plexium Enter into Multi-target Strategic Collaboration to Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions

San Diego, California, [April 28, 2022] – Plexium, Inc. (Plexium) and AbbVie (NYSE: ABBV) have entered into an exclusive strategic…

Inozyme Pharma Announces Positive Preliminary Data from Phase 1/2 Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency

Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization,…

Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunteers

Marks key milestone as Evommune's first clinical program which should allow EVO101 to rapidly advance into Phase 2a